Predictors of Paravalvular Regurgitation After Implantation of the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Valve (from the REPRISE II Trial Extended Cohort).

Blackman DJ, Meredith IT, Dumonteil N, Tchétché D, Hildick-Smith D, Spence MS, Walters DL, Harnek J, Worthley SG, Rioufol G, Lefèvre T, Houle VM, Allocco DJ, Dawkins KD.

Open source

DOI
10.1016/j.amjcard.2017.04.026
Published
2017-04-27
Container
Am J Cardiol
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.amjcard.2017.04.026,
  title = {Predictors of Paravalvular Regurgitation After Implantation of the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Valve (from the REPRISE II Trial Extended Cohort).},
  author = {Blackman DJ and  Meredith IT and  Dumonteil N and  Tchétché D and  Hildick-Smith D and  Spence MS and  Walters DL and  Harnek J and  Worthley SG and  Rioufol G and  Lefèvre T and  Houle VM and  Allocco DJ and  Dawkins KD.},
  year = {2017},
  journal = {Am J Cardiol},
  doi = {10.1016/j.amjcard.2017.04.026},
  url = {https://doi.org/10.1016/j.amjcard.2017.04.026}
}

RIS

TY  - JOUR
TI  - Predictors of Paravalvular Regurgitation After Implantation of the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Valve (from the REPRISE II Trial Extended Cohort).
AU  - Blackman DJ
AU  -  Meredith IT
AU  -  Dumonteil N
AU  -  Tchétché D
AU  -  Hildick-Smith D
AU  -  Spence MS
AU  -  Walters DL
AU  -  Harnek J
AU  -  Worthley SG
AU  -  Rioufol G
AU  -  Lefèvre T
AU  -  Houle VM
AU  -  Allocco DJ
AU  -  Dawkins KD.
PY  - 2017
JO  - Am J Cardiol
DO  - 10.1016/j.amjcard.2017.04.026
UR  - https://doi.org/10.1016/j.amjcard.2017.04.026
ER  - 

APA

DJ, B., IT, M., N, D., D, T., D, H., MS, S., DL, W., J, H., SG, W., G, R., T, L., VM, H., DJ, A., & KD., D. (2017). Predictors of Paravalvular Regurgitation After Implantation of the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Valve (from the REPRISE II Trial Extended Cohort).. Am J Cardiol. https://doi.org/10.1016/j.amjcard.2017.04.026

Source records